HIBM Research Group (HRG) is a 501(c)(3) non-profit public benefit corporation, engaged in collaborative biomedical research towards accelerating the development of therapy for HIBM
We refers patients for clinical testing to laboratories accredited by the College of American Pathologists (CAP), and licensed by the Department of Health Services Clinical Laboratory Improvement Amendments program (CLIA) and California Department of Health Laboratory Field Services (LFS).
The College of American Pathologists (CAP) Laboratory Accreditation is an internationally recognized program and the only one of its kind that utilizes teams of practicing laboratory professionals as inspectors. Designed to go well beyond regulatory compliance, the program helps laboratories achieve the highest standards of excellence to positively impact patient care.
The Clinical Laboratory Improvement Amendments (CLIA) program objective is to ensure quality laboratory testing. In total, CLIA covers over 200,000 laboratory entities.
The California Laboratory Field Services (LFS) mission is to ensure quality standards in clinical and public health laboratories and laboratory scientists through licensing, examination, inspection, education, and proficiency testing. LFS provides oversight for clinical and public health laboratory operations and for testing in clinical laboratories.